Meeting
2023 ASCO Annual Meeting
Somatic profiling guides germline genetic testing in patients with mutations in cancer predisposition genes.
Authors
Sourat Darabi
Hoag Family Cancer Institute, Newport Beach, CA
Sourat Darabi , Jeanne Homer , Chelsey Weatherill , Carlos E Zuazo , Valentina Dalili-Shoaie , Michael J. Demeure , David R. Braxton
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Hereditary Cancer Syndromes
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10608)
DOI
10.1200/JCO.2023.41.16_suppl.10608
Abstract #
10608
Poster Bd #
241
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Identification of potential germline (GL) variants by routine clinical comprehensive genomic profiling (CGP) and confirmatory GL testing in 24 tumor types.
First Author: Kristen Hanson
Poster
2019 ASCO Annual Meeting
Tumor sequencing with germline genetic testing: Identification of patients with hereditary cancer and precision treatment eligibility.
First Author: Scott T. Michalski
Poster
2022 ASCO Genitourinary Cancers Symposium
Putative germline findings in tumor-only and liquid biopsy sequencing in veterans with aggressive prostate cancer.
First Author: Kara Noelle Maxwell
Poster
2019 ASCO Annual Meeting
Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women’s Health Initiative.
First Author: Allison W. Kurian